ArticleInvestigative radiology2025
Optimizing MRI Protocols for Brain Radiosurgery: The Role of Sequence and Contrast Agent Timing.
Article in Investigative radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeAccurate target volume delineation is critical for effective stereotactic radiotherapy (SRT) of brain metastases. This study systematically investigates how MRI sequence selection and the time elapsed after contrast agent (CA) administration affect the apparent metastases volumes, with the goal of optimizing MRI protocols for radiation therapy planning. MATERIALS AND
methodsA total of 49 patients with 414 brain metastases were included and randomized into 6 groups with varying imaging sequences (MPRAGE, SPACE, and VIBE) and timepoints after CA administration. Lesions smaller than 0.03 cm3 were excluded due to resolution limitations. Lesion volumes were independently assessed by radiology and radiation oncology specialists, and mean values were analyzed. The effects of MRI sequence and time delay on lesion volume were evaluated using t tests, ANOVA, and multiple linear regression.
resultsBoth MRI sequence and CA timing significantly influenced measured volumes. On average, SPACE volumes were 20% larger than MPRAGE, and VIBE volumes were 10% larger than SPACE, independent of timing. Lesion volumes increased progressively with time after CA administration at rates of 0.63%, 0.58%, and 0.36% per minute for MPRAGE, SPACE, and VIBE, respectively. Smaller lesions (<1 cm3) showed greater relative intersequence differences, primarily due to variations in visible lesion borders.
conclusionsBoth MRI sequence choice and imaging time after CA administration significantly affect the apparent volume of brain metastases in SRT planning. Although SPACE and VIBE sequences enhance small lesion detection, they may also increase border blurring and inter-rater variability. Standardizing protocols to account for these factors is essential for improving delineation accuracy, reducing toxicity risk, and optimizing SRT outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.